Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD) [NA]
A completed clinical trial evaluated aripiprazole for patients with schizophrenia who also exhibit obsessive-compulsive symptoms.
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, signaling an approved update to the…
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action represents a regul…
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC (ANDA 084115).
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: The Bioequivalence Of Two Different Lurasidone Formulations In Patients [Phase 1]
Phase 1 study comparing the bioavailability of two lurasidone formulations in patients with schizophrenia to determine equivalence.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Midazolam Drug-Drug Interaction Study With Lurasidone HCl [Phase 1]
Phase 1 study completed to evaluate the pharmacokinetic interaction and safety between midazolam and lurasidone hydrochloride in schizophren…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Digoxin Drug-Drug Interaction With Lurasidone HCl [Phase 1]
Phase 1 study evaluating the potential drug-drug interaction between digoxin and lurasidone hydrochloride in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Lithium Drug-Drug Interaction Study With Lurasidone HCl [Phase 1]
The Phase 1 trial update reports completion of a lithium and lurasidone hydrochloride drug-drug interaction study in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl [Phase 1]
This completed Phase 1 pharmacokinetic study investigates how calorie intake and fat content influence the absorption and exposure of lurasi…
-
FDA approval · 2011-09-07FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
The FDA approved a supplemental application for Fanapt (iloperidone) from Vanda Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS) [NA]
A terminated clinical trial evaluated cognitive outcomes with aripiprazole (Abilify) in patients with schizophrenia (also including schizoaf…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) [NA]
A terminated clinical trial evaluated cognitive outcomes with aripiprazole (Abilify) in patients with schizophrenia and schizoaffective diso…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: PHARMO Institute Seroquel Safety Study
A completed PHARMO Institute safety study evaluating Seroquel (quetiapine) across schizophrenia, major depressive disorder, bipolar disorder…
-
FDA approval · 2011-09-02FDA Approved: HALOPERIDOL — Original Application (Sagent Pharmaceuticals)
FDA approved HALOPERIDOL lactate injectable as an Original Application by Sagent Pharmaceuticals. This adds a generic HALOPERIDOL lactate pr…
-
FDA approval · 2011-08-26FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Risperidone by Torrent Pharmaceuticals Limited, indicating approval of a generic version of the …
-
FDA approval · 2011-08-25FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' supplemental application for risperidone, authorizing a generic version of the antipsychotic. The …
-
FDA label_change · 2011-08-24FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA page documents a supplemental application for RISPERDAL M-TAB (risperidone) by Janssen Pharmaceuticals, typically filed to support l…
-
FDA approval · 2011-08-24FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
The FDA approved a supplemental application for risperidone from Janssen Pharmaceuticals, Inc. The approval updates the drug's labeling.
-
FDA approval · 2011-08-24FDA Approved: RISPERIDONE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA's generic risperidone (ANDA201003).
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) [Phase 4]
A Phase 4 clinical trial evaluates whether Seroquel-XR (quetiapine extended-release) improves neurocognitive function in people at risk for …
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
A clinical trial evaluated the effectiveness of atypical antipsychotics on anhedonic features in schizophrenia patients. The trial status is…
-
FDA approval · 2011-08-16FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Risperidone from Torrent Pharmaceuticals Limited, authorizing changes to the approved generic pr…
-
FDA approval · 2011-08-12FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
The FDA granted a supplemental approval for Haloperidol Decanoate submitted by Patriot Pharmaceuticals LLC.
-
FDA label_change · 2011-08-09FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for SAPHRIS (asenapine) submitted by Allergan to update the product labeling.